MyAverix Finance
TWO · Healthcare
Lukas Biomedical Inc. (6814)
Biotechnology
Lukas Biomedical Inc. (6814) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $1.10B, P/E ratio is 18.00, net margin is -53.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6814
Lukas Biomedical Inc. (6814) — FAQ
What is Lukas Biomedical Inc.'s market cap?
Lukas Biomedical Inc. (6814) has a reported market cap of $1.10B (data as of 2026-03-29).
What is 6814's P/E ratio?
The price-to-earnings (P/E) ratio for Lukas Biomedical Inc. (6814) is 18.00 (data as of 2026-03-29).
Does Lukas Biomedical Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Lukas Biomedical Inc. (6814). Check the MyAverix Finance app for the latest dividend data.
What sector is Lukas Biomedical Inc. in?
Lukas Biomedical Inc. (6814) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6814 listed on?
6814 is listed on TWO.
What is Lukas Biomedical Inc.'s net margin?
Lukas Biomedical Inc. (6814) reports a net margin of -53.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.